These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 3806987)

  • 1. [Ferritin levels of the serum and red blood cells in patients with myelodysplastic syndrome (MDS)].
    Sakurada K; Miyazaki T
    Rinsho Ketsueki; 1986 Sep; 27(9):1789-95. PubMed ID: 3806987
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical significance of red cell ferritin H and L subunits in myelodysplastic syndrome].
    Kobayashi T
    Hokkaido Igaku Zasshi; 1994 May; 69(3):587-99. PubMed ID: 7927183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Myelodysplastic syndromes and refractory anemias with reference to the erythropoietic abnormalities].
    Yoshida Y
    Nihon Rinsho; 1991 Mar; 49(3):587-92. PubMed ID: 2041184
    [No Abstract]   [Full Text] [Related]  

  • 4. Oxidative stress levels in myelodysplastic syndrome patients: their relationship to serum ferritin and haemoglobin values.
    Saigo K; Takenokuchi M; Hiramatsu Y; Tada H; Hishita T; Takata M; Misawa M; Imoto S; Imashuku S
    J Int Med Res; 2011; 39(5):1941-5. PubMed ID: 22117997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro stimulation of erythropoiesis by stem cell factor alone in myelodysplastic syndrome patients with elevated endogenous erythropoietin serum levels.
    Zwierzina H; Bammer T; Rollinger-Holzinger I; Herold M; Fenaux P; Nüssler V; Hoflehner E; Geissler D
    Clin Cancer Res; 1996 Jun; 2(6):1031-8. PubMed ID: 9816264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Classification of the myelodysplastic syndromes.
    Bennett JM
    Clin Haematol; 1986 Nov; 15(4):909-23. PubMed ID: 3471370
    [No Abstract]   [Full Text] [Related]  

  • 7. Current use of recombinant human erythropoietin (r-huEPO) in the management of symptomatic anaemia in patients with myelodysplastic syndromes (MDS).
    Marques da Costa R
    Sangre (Barc); 1994 Apr; 39(2):105-10. PubMed ID: 8059287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Erythropoietin treatment of anemia associated with multiple myeloma (MM) and myelodysplastic syndrome (MDS)].
    Qiao ZH
    Zhonghua Zhong Liu Za Zhi; 1993 Mar; 15(2):122-4. PubMed ID: 8223121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myelodysplastic patients with raised percentage of hypochromic red cells have evidence of functional iron deficiency.
    Murphy PT; Quinn JP; O'Donghaile D; Swords R; O'Donnell JR
    Ann Hematol; 2006 Jul; 85(7):455-7. PubMed ID: 16568320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical significance of erythrocyte ferritin in refractory anemia and chronic myeloid leukemia].
    Tsvetaeva NV; Vinogradova OIu; Levina AA; Tsibul'skaia MM; Diagileva OA; Sokolova MA; Kuznetsov SV; Turkina AG; Khoroshko ND
    Ter Arkh; 2002; 74(7):18-22. PubMed ID: 12181828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of transfusion dependency and secondary iron overload on the survival of patients with myelodysplastic syndromes.
    Malcovati L
    Leuk Res; 2007 Dec; 31 Suppl 3():S2-6. PubMed ID: 18037415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retrospective nationwide survey of Japanese patients with transfusion-dependent MDS and aplastic anemia highlights the negative impact of iron overload on morbidity/mortality.
    Takatoku M; Uchiyama T; Okamoto S; Kanakura Y; Sawada K; Tomonaga M; Nakao S; Nakahata T; Harada M; Murate T; Ozawa K;
    Eur J Haematol; 2007 Jun; 78(6):487-94. PubMed ID: 17391310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myocardial iron loading by magnetic resonance imaging T2* in good prognostic myelodysplastic syndrome patients on long-term blood transfusions.
    Chacko J; Pennell DJ; Tanner MA; Hamblin TJ; Wonke B; Levy T; Thomas PW; Killick SB
    Br J Haematol; 2007 Sep; 138(5):587-93. PubMed ID: 17610536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluctuations of haemoglobin values in myelodysplastic syndrome.
    Demiroglu H; Dündar S
    N Z Med J; 1996 Mar; 109(1017):82-3. PubMed ID: 8606829
    [No Abstract]   [Full Text] [Related]  

  • 15. Detection of small populations of CD59-deficient erythrocytes in patients with aplastic anemia or myelodysplastic syndrome and normal individuals.
    Yamaguchi M; Machii T; Azenishi Y; Nishimura J; Shibano M; Kanakura Y; Kitani T
    Blood Cells Mol Dis; 2000 Jun; 26(3):247-54. PubMed ID: 10950945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Peculiarities of cytogenetic changes in different types of myelodysplastic syndrome].
    Lozyns'ka MP; Vyhovs'ka IaI; Tomashevs'ka NIa; Masliak ZV; Lozyns'kyĭ RIu; Novak VL
    Tsitol Genet; 2009; 43(1):61-8. PubMed ID: 19663317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Preliminary results of erythropoietin treatment of anemia in myelodysplastic syndromes and chronic lymphocytic leukemia].
    Gałeza-Obrepalska B; Dwilewicz-Trojaczek J; Paszkowska M; Kuratowska Z
    Pol Tyg Lek; 1996 May; 51(19-22):285-8. PubMed ID: 9289712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neither serum ferritin nor the number of red blood cell transfusions affect overall survival in refractory anemia with ringed sideroblasts.
    Chee CE; Steensma DP; Wu W; Hanson CA; Tefferi A
    Am J Hematol; 2008 Aug; 83(8):611-3. PubMed ID: 18442062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypochromic red blood cells in low-risk myelodysplastic syndromes: effects of treatment with hemopoietic growth factors.
    Ljung T; Bäck R; Hellström-Lindberg E
    Haematologica; 2004 Dec; 89(12):1446-53. PubMed ID: 15590394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary hepcidin excretion in patients with low grade myelodysplastic syndrome.
    Murphy PT; Mitra S; Gleeson M; Desmond R; Swinkels DW
    Br J Haematol; 2009 Feb; 144(3):451-2. PubMed ID: 19076175
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.